US-based diabetes prevention startup Omada Health has announced $23m in series B funding in a round featuring healthcare consortium Kaiser Permanente’s corporate venturing unit, Kaiser Permanente Ventures, according to TechCrunch.
Andreessen Horowitz led the round, and funding also came from existing investors U.S Venture Partners and The Vertical Group. To date, Omada has raised $28.5 million in investment from backers also including New Enterprise Associates, Aberdare Ventures, Kapor Capital, TriplePoint Capital and Rock Health.
Omada provides digital therapy programmes for people chronic diseases such as type 2 diabetes. The company’s team features former employees of Google, Amazon and design firm IDEO.
Omada co-founder and CEO Sean Duffy told TechCrunch: “We’ve seen companies like Fitbit and Weight Watchers increasingly eyeing the enterprise healthcare space. And big health plans like United Healthcare are creating potential competitors too. We bridge between these two worlds, and we want to continue to grow in a way that others can’t yet.”